Mercado global de equipamentos de aférese – Tendências do setor e previsão para 2031

Análise e dimensão do mercado de equipamentos de aférese

Espera-se que o mercado global de equipamentos de aférese testemunhe um crescimento constante nos próximos anos. A crescente prevalência de doenças do sangue e a crescente necessidade de componentes sanguíneos são os principais factores que impulsionam a procura de equipamento de aférese. O crescente número de casos de trauma e acidentes rodoviários que necessitam de transfusões de sangue irá aumentar ainda mais o crescimento do mercado. Além disso, o aumento dos casos de doenças crónicas, como o cancro, em que a aférese desempenha um papel vital no tratamento, está a impulsionar as vendas de soluções avançadas de aférese.

A Data Bridge Market Research analisa que o mercado global de equipamentos de aférese, que foi de 3,7 mil milhões de dólares em 2023, deverá atingir até 8,65 mil milhões de dólares até 2031, e deverá passar por um CAGR de 11,2% durante o período de previsão de 2024 a 2031. “Descartáveis ​​kits de aférese” domina o segmento de equipamentos do mercado devido à crescente procura de melhores métodos de diagnóstico nos pacientes. Além dos insights sobre cenários de mercado, tais como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também análise especializada aprofundada, epidemiologia de pacientes, análise de pipeline, análise de preços, e quadro regulamentar.

Âmbito do relatório e segmentação de mercado

Definição de mercado

O equipamento de aférese refere-se a dispositivos médicos concebidos para a separação automatizada de componentes sanguíneos durante procedimentos de aférese. A férese é um processo terapêutico que envolve a remoção de componentes específicos do sangue de um paciente, como o plasma, as plaquetas ou os glóbulos brancos, ao mesmo tempo que devolve os restantes componentes sanguíneos à circulação do paciente. O equipamento de aférese consiste normalmente numa máquina equipada com sistemas de centrifugação ou filtração que permitem a separação dos componentes do sangue com base nas suas propriedades físicas, como a densidade ou o tamanho.

Dinâmica do mercado de equipamentos de aférese

Motoristas

• Avanços Tecnológicos

As inovações tecnológicas nos equipamentos de aférese melhoraram significativamente a eficiência, a segurança e a usabilidade destes dispositivos. As funcionalidades avançadas de automatização, os algoritmos de software melhorados e o desenvolvimento de kits descartáveis ​​simplificaram os procedimentos, reduziram os tempos dos procedimentos e minimizaram o risco de eventos adversos. Por exemplo, a introdução da centrifugação de fluxo contínuo e de procedimentos guiados por software levou a uma separação mais precisa e eficaz dos componentes sanguíneos. Além disso, a integração de sistemas de monitorização avançados e recursos de conectividade permite a análise de dados em tempo real e a monitorização remota, melhorando os resultados dos doentes e a eficiência operacional. À medida que os prestadores de cuidados de saúde dão cada vez mais prioridade à adopção de tecnologias de ponta para optimizar os cuidados aos doentes, prevê-se que a procura de equipamentos avançados de aférese continue a aumentar a nível mundial.

• Aumento da prevalência de doenças crónicas

The increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and cardiovascular diseases is driving the demand for apheresis procedures worldwide. Apheresis therapy plays a crucial role in the management of these conditions by removing harmful substances from the blood, such as excess antibodies, toxins, or cancerous cells. With the growing burden of chronic diseases globally, particularly in aging populations and emerging economies undergoing epidemiological transitions, there is a growing demand for effective therapeutic interventions such as apheresis. Moreover, advancements in precision medicine and personalized therapies have expanded the application of apheresis procedures, creating new opportunities for market growth. As healthcare systems strive to address the rising demand for advanced treatment modalities, the market for apheresis equipment is expected to witness sustained growth in the coming

Opportunities

• Expansion in Emerging Markets

As healthcare infrastructure continues to improve and economies develop in regions such as Asia-Pacific, Latin America, and the Middle East, there is a growing demand for advanced medical technologies, including apheresis equipment. Factors such as increasing prevalence of chronic diseases, rising healthcare expenditure, and expanding access to healthcare services are driving the demand for apheresis procedures in these markets. Companies that strategically expand their presence in emerging markets through partnerships, distribution agreements, or direct investments can tap into this growing demand and capitalize on the untapped market potential to addressing the specific needs and preferences of these markets, manufacturers can establish strong footholds, drive revenue growth, and contribute to improving healthcare outcomes on a global scale.

Restraints/Challenges

• High Initial Investment Costs

Apheresis equipment typically requires a significant upfront investment for procurement, installation, and training. The complex technology and specialized components contribute to high costs, which may deter healthcare facilities from adopting or upgrading their apheresis systems. Additionally, maintenance and servicing expenses can further strain budgets over time. This financial barrier could limit market growth, particularly in regions with limited healthcare budgets or reimbursement constraints. Consequently, healthcare providers may opt for alternative treatment modalities or delay equipment upgrades, impacting market expansion.

• Stringent Regulatory Compliance Requirements

 The global apheresis equipment market is subject to stringent regulatory standards and certification processes imposed by regulatory authorities such as the FDA (Food and Drug Administration) in the United States and the European Medicines Agency (EMA) in Europe. Compliance with these regulations necessitates rigorous testing, documentation, and quality control measures throughout the manufacturing and distribution processes. Failure to meet regulatory requirements can result in product recalls, fines, or delays in market entry, thereby impeding manufacturers' ability to introduce new or upgraded equipment. Moreover, navigating the regulatory landscape incurs additional time and resources, potentially slowing down innovation and product development cycles. As a result, companies operating in the apheresis equipment market must allocate substantial resources to ensure compliance, which may hinder market growth and innovation.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

• In May 2023, Terumo Corporation a medical device company launched the first training program of its kind to help cell and gene therapy manufacturers improve their cell collection processes and accelerate the commercialization of therapeutics. It will help to trains the participants in apheresis market for the better skills
• In January 2020, Fresenius Kabi AG a pharmaceutical company inaugurated the USD 32.2 Mn expansion of transfusion and apheresis disposables plant in Dominican Republic. This plant expansion will strengthen the company’s role as a major global exporter of apheresis and plasma collection sets

Apheresis Equipment Market Scope

The market is segmented on the basis of equipment type, technology type, procedure type, application, end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

 Equipment Type

• Disposable Apheresis Kits
• Apheresis Machines

Technology Type

• Centrifugation
• Membrane Filtration

 Procedure Type

• Photopheresis
• Plasmapheresis
• LDL Apheresis
• Plateletpheresis
• Leukapheresis
• Erythrocytapheresis,
• Others
  • Lymphopheresis
  •  lipidpheresis

 Application

• Renal Disorders
• , Neurological Disorders
• Hematological Disorders
• Other Disorders

End User

• Hospitals and Clinic
• Ambulatory Surgical Centers
• Blood Donation Centers
• Others

Apheresis Equipment Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided country, Equipment Type, Technology Type, Procedure Type, Application, End User as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.

North America is expected to be the largest market for apheresis equipment market due to a strong presence of leading players in the region. The U.S. is home to many large multinational companies, such as Haemonetics Corporation and Terumo BCT, which have a significant market share in blood component collection and therapeutic apheresis products globally.

Asia Pacific is expected to be the fastest-growing market for apheresis equipment, which is expected to grow at a CAGR of over 10.2% during the forecast period. The growth of the market in Asia Pacific is attributed to the large patient pool, increasing healthcare expenditure, and improving healthcare infrastructure in the region

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The market also provides you with a detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for the market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for the historic period 2016-2021.

Competitive Landscape and Apheresis Equipment Market Share Analysis

O cenário competitivo do mercado fornece detalhes dos concorrentes. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produtos, largura e amplitude do produto, domínio da aplicação. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Alguns dos principais players que operam no mercado são:

• Asahi Kasei Medical Co., Ltd. (Japão)
•  Terumo Corporation, Inc.
• (EUA)
• (EUA)
• (EUA)
• Braun Melsungen AG (Alemanha)
• HemaCare Corporation (EUA)
• Haemonetics Corporation (EUA)
• Miltenyi Biotec (Alemanha)
• NxStage Médica (EUA)
• Kaneka Medix Corporation (Japão)

SKU-46707